In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
Cell & Gene: The Podcast
00:00
The Importance of Building a Manufacturing Facility in the Cell and Gene Therapy Industry
This chapter highlights the decision to create their own manufacturing facility and the benefits it provides in terms of supply chain control and technological iteration. It also discusses the challenges and importance of industry experience in vector manufacturing for CAR T-cell therapeutics.
Transcript
Play full episode
